DNLIDenali Therapeutics Inc.

$19.46+53% 1Y

Is the price fair?

What DNLI's price assumes

Price / book
5.55

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
5.55
Market capitalisation
$3.92B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.